Quickly uncover the breadth and depth of the editorial offerings found only in MedTech Strategist and Market Pathways – the medtech industry’s leading sources of global business, regulatory, and reimbursement analysis and intelligence on an all-in-one, digital platform. Think Strategically. Subscribe Today
In this week’s Pathways Picks: FDA outlines new centralized operations and announces user fee rate increases; RAPID proposal approaches; South Korea refines rules for when AI software requires a clinical study; Europe implements AI reforms; and EU expert panel opinions are assessed.
At a NASS Summit on Spine Innovation, battle-hardened entrepreneurs, surgeons, investors, and healthcare system executives discussed lessons learned and takeaways for building companies in a financially constrained environment.
Did FDA clear a product that incorporates a large language model? Excerpted from Pathways’ Picks July 1: FDA Clears an LLM? Asia Updates, Ireland’s Elevation, and More.